1114563-10-8 Usage
General Description
5-bromo-1-(2,2,2-trifluoroethyl)pyridin-2(1H)-one is a chemical compound that belongs to the pyridinone class of compounds. It is characterized by a bromine atom attached to the 5-carbon position of the pyridinone ring, and a 2,2,2-trifluoroethyl group attached to the 1-carbon position. 5-bromo-1-(2,2,2-trifluoroethyl)pyridin-2(1H)-one is commonly used in organic synthesis and medicinal chemistry research due to its potential pharmacological activities. Its structure and properties make it a valuable building block for the development of new drugs and agrochemicals. Additionally, the presence of the bromine atom and the trifluoroethyl group provides opportunities for further modifications to enhance the compound's biological activities. Overall, 5-bromo-1-(2,2,2-trifluoroethyl)pyridin-2(1H)-one is an important compound with diverse applications in the field of chemistry and pharmaceutical research.
Check Digit Verification of cas no
The CAS Registry Mumber 1114563-10-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,1,4,5,6 and 3 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1114563-10:
(9*1)+(8*1)+(7*1)+(6*4)+(5*5)+(4*6)+(3*3)+(2*1)+(1*0)=108
108 % 10 = 8
So 1114563-10-8 is a valid CAS Registry Number.
1114563-10-8Relevant articles and documents
SUBSTITUTED 2-AMINO-PYRAZOLYL-[1,2,4]TRIAZOLO[1,5A] PYRIDINE DERIVATIVES AND USE THEREOF
-
Page/Page column 460, (2020/10/27)
Provided herein are 2-amino-pyrazolyl-[ 1,2,4]triazolo [1,5a]pyridine derivatives. Such compounds are useful, for example, for the treatment and/or prevention of neurodegenerative diseases or disorders such as ophthalmological neurodegenerative disorders. This disclosure also features compositions containing the same as well as methods of using and making the same.
BENZOTHIOPHENE SULFONAMIDES AND OTHER COMPOUNDS THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN
-
Page/Page column 312, (2013/12/03)
The present invention relates to benzothiophene sulfonamides and other compounds that interact with glucokinase regulatory protein. In addition, the present invention relates to methods of treating type 2 diabetes, and other diseases and/or conditions where glucokinase regulatory protein is involved using the compounds, or pharmaceutically acceptable salts thereof, and pharmaceutical compositions that contain the compounds, or pharmaceutically acceptable salts thereof.